Unicycive Therapeutics In...

AI Score

XX

Unlock

0.55
-0.02 (-4.33%)
At close: Apr 01, 2025, 3:59 PM
0.58
6.32%
After-hours: Apr 01, 2025, 07:59 PM EDT

Unicycive Therapeutics Income Statement

Year FY24 FY23 FY22 FY21 FY20
Revenue n/a 675K 951K n/a n/a
Cost of Revenue n/a n/a 7K 1K n/a
Gross Profit n/a 675K 944K -1K n/a
Operating Income -32.12M -20.77M -18.05M -8.98M -2.02M
Interest Income 1.26M 615K 6K 628K 244K
Pretax Income -37.82M -30.54M -18.06M -10.02M -2.26M
Net Income -37.82M -30.54M -18.06M -10.63M -2.51M
Selling & General & Admin 12.1M 8.55M 6.57M 2.9M 1M
Research & Development 20.01M 12.9M 12.44M 6.08M 1.01M
Other Expenses n/a n/a n/a n/a n/a
Operating Expenses 32.12M 21.45M 19M 8.98M 2.02M
Interest Expense -71K 82K 6K 628K 244K
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses n/a 21.45M 19M 8.98M 2.02M
Income Tax -37.82M n/a 6K 615K 244K
Shares Outstanding (Basic) 669.85M 24.54M 15.06M 15M 15.25M
Shares Outstanding (Diluted) 669.85M 24.54M 15.06M 15M 15.25M
EPS (Basic) -0.06 -1.28 -1.2 -0.71 -0.16
EPS (Diluted) n/a n/a n/a n/a n/a
EBITDA -32.12M -30.18M -18.05M -8.98M n/a
Depreciation & Amortization n/a 284K 7K 1K 2.02M